• Follow
  • About
  • News
  • Contact Us

TELEHEALTH WINS REPRIEVE: ATA AND ATA ACTION COMMEND DEA AND SAMHSA FOR EXTENSION OF FLEXIBILITIES FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES

by ATA Action | May 9, 2023 | Press Releases

WASHINGTON, DC, MAY 9, 2023 – The American Telemedicine Association (ATA) and ATA Action issued the following statement in response to the Drug Enforcement Administration’s (DEA) and Substance Abuse and Mental Health Services Administration’s (SAMHSA) temporary...

ATA ACTION SUBMITS COMPREHENSIVE RECOMMENDATIONS TO DEA ON PROPOSED RULES REGARDING REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES

by ATA Action | Mar 30, 2023 | Press Releases

WASHINGTON, DC, MARCH 29, 2023 – ATA Action officially submitted comprehensive comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding the remote prescribing of controlled substances. In two letters to the DEA, ATA Action outlined...

ATA Action is working to ensure temporary flexibilities put in place during the COVID-19 public health emergency last at least through 2023, avoiding a “telehealth cliff” while working to make policies permanent.

ATA Action

901 N Glebe Road, Suite 850 Arlington, VA 22203 | info@ataaction.org

  • Follow
Get In Touch

Name(Required)
This field is for validation purposes and should be left unchanged.